About us

We are an European compay based in The Netherlands, committed to delivering personalized, data-driven solutions that are designed to meet the unique needs of each cancer patient, thereby enhancing treatment efficacy and improving patient outcomes.

Accelerated innovation

Spearhead the development of groundbreaking cancer therapies by utilizing molecular insights to discover and optimize new drugs more efficiently.

Enhanced diagnostic capabilities

Develop state-of-the-art diagnostic tools and molecular biomarkers that provide detailed insights into cancer pathology, facilitating early and accurate diagnosis.

Individualized treatment plans

Employ molecular modeling to create highly personalized treatment regimens that align with the specific genetic and molecular profiles of each patient’s cancer.

Education and advocacy

Lead initiatives to educate clinicians, patients, and the public about the transformative potential of molecular modeling in cancer care, promoting its widespread adoption in clinical practice.

Our team

Our commitment to scientific excellence and continuous innovation drives us that every patient receives the most effective care possible.

All of our members

Rosita Joranova

Rositsa Jordanova
Chief executive officer

Josef melcr

Josef Melcr
Chief product & tech officer

Matthew Groves

Matthew Groves
Chief scientific officer

Hoang Nguyen

Hoang Nguyen
Chief operating officer

Protyon is trusted and utilized by hospitals and our partners

Our story

Our mission is to treat cancer therapy through the power of computational modeling and predictive analytics. We aim to deliver personalized treatment plans that optimize outcomes and enhance the quality of life for cancer patients. 

01

Highest levels of accuracy

Our focus on precise molecular insights ensures that treatments are specifically targeted and highly effective, leading to better patient outcomes.

02

Scientific excellence

We aim for highest standards of scientific excellence. Our commitment to quality ensures that our innovations deliver a broad range of benefits, improving the lives of cancer patients.

03

Personalized treatment

By utilizing molecular modeling, we tailor cancer treatments to the unique genetic and molecular profiles of each patient, ensuring the most effective and individualized care.

Talk to us

Feel free to reach out to us and book an appointment with one of our experts in the field of molecular modeling. We are here to support you. 

Please enable JavaScript in your browser to complete this form.
Hoang Nguyen
Chief Operation Officer